Filter your results
- 2
- 1
- 3
- 3
- 1
- 1
- 1
- 3
- 3
- 3
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.Oncotarget, 2016, 7 (14), pp.18183-203. ⟨10.18632/oncotarget.7784⟩
Journal articles
pasteur-01351190v1
|
||
|
Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.Oncotarget, 2015, 6 (38), pp.40970-80. ⟨10.18632/oncotarget.5403⟩
Journal articles
pasteur-01352682v1
|
||
|
Expression and functions of galectin-7 in ovarian cancer.Oncotarget, 2014, 5 (17), pp.7705-7721. ⟨10.18632/oncotarget.2299⟩
Journal articles
pasteur-01135767v1
|